Integra Lifesciences HLD (iart 0.5 08/15/25)

13F holders, Q3 2024 (September 30)
3holders −3
1new positions
4sold out
$1.09avg. 13F price*

At the end of Q3 2024, 3 institutions reported holding Integra Lifesciences HLD (iart 0.5 08/15/25) in their 13F filings, down 3 from Q2 2024. 1 opened new positions and 4 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.9M), Oddo BHF Asset Management Sas ($429K) and Comerica Bank ($5K).

Company
Integra Lifesciences HLD (iart 0.5 08/15/25)
CUSIP
457985AM1
Latest filing quarter
Q2 2025

History

Number of 13F holders

02468 Q1 2024: 8Q1 2024Q2 2024: 6Q2 2024Q3 2024: 3Q3 2024Q4 2024: 2Q4 2024Q1 2025: 1Q1 2025Q2 2025: 2Q2 2025

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions1$5K
Exits4$1.7M

All 13F filers, Q2 2024 → Q3 2024: 5,000 shares bought and 1,766,000 shares sold, net −1,761,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 3 holders

BNP PARIBAS ASSET MANAGEMENT Holding S.A. 0.01% No change 3,000,000 $2.9M
Oddo BHF Asset Management Sas 0.02% — 451 $429K
Comerica Bank 0.00% New 5,000 $5K

"% of holder's portfolio" is INTEGRA LIFESCIENCES HLD (IART 0.5 08/15/25)'s weight in each manager's 13F, not the share of Integra Lifesciences HLD (iart 0.5 08/15/25) the manager owns.